Skip to main content

Advertisement

Table 4 Best tumor responses for patients with unresectable hepatocellular carcinoma who underwent either HAIC or TACE

From: Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

Response HAIC group [cases (%)] TACE group [cases (%)] P
Objective response 20 (54.1) 4 (9.8) < 0.001
Disease control 31 (83.8) 21 (52.5) 0.004
 Complete response 0 0 1.000
 Partial response 20 (52.6) 4 (9.8) < 0.001
 Stable disease 11 (28.9) 17 (41.5) 0.347
Progressive disease 6 (15.8) 19 (46.3) 0.004
Not evaluable 1 (2.6) 1 (2.4)  
  1. HAIC hepatic artery infusion chemotherapy; TACE transarterial chemoembolization
  2. P values were calculated using a two-sided Chi square test